Read this first
This is plain-language harm-reduction information, not medical advice. Peptides discussed here are research compounds; most are not approved for human use. People will use them either way — we would rather they have the facts.
On 24 October 2025 the UK medicines regulator, the MHRA, announced it had dismantled an illicit production site for weight-loss injections in an industrial warehouse in Northampton. According to the MHRA, it is the first illicit production site for weight-loss medicines found in the UK, and it is believed to be the world's largest single seizure of trafficked weight-loss medicines.
What was seized
According to the MHRA's press release, a two-day operation by its Criminal Enforcement Unit, supported by Northamptonshire Police, recovered:
- more than 2,000 unlicensed pens labelled as retatrutide and tirzepatide
- tens of thousands of empty weight-loss pens
- raw chemical ingredients and manufacturing and packaging equipment
- around £20,000 in cash
The MHRA put the street value of the finished products at more than £250,000.
What officials said
Health Secretary Wes Streeting was quoted as saying the products were made with no regard for safety or quality and posed a major risk to unwitting customers. Andy Morling, head of the MHRA's Criminal Enforcement Unit, was quoted describing the products as untested, unauthorised and potentially deadly. Coverage of the raid on Diabetes.co.uk quoted the regulator's warning that there are no guarantees on dose, ingredients or sterility, and that contamination and mis-dosing can cause serious harm.
Why this matters if you are considering peptides
Two details stand out. First, the pens were being filled with tirzepatide and retatrutide, the same two drugs that are most often discussed in peptide communities. Second, retatrutide is not approved in the UK outside clinical trials, so, as Diabetes.co.uk reported from the MHRA, any product claiming to contain it is illegal by definition.
A professional-looking pen is not evidence of a genuine product. If the pen was filled in a warehouse, the label, the box and even a batch number can be printed to order. The risks the MHRA highlights are the practical ones: you cannot know how much active ingredient is inside, what else is in there, or whether it is sterile. An injectable that is wrongly dosed or contaminated can cause harm that a tablet usually would not.
Plain-English takeaway: if a weight-loss injection came from social media, a marketplace listing or an unofficial website, you cannot treat it as the real thing, however good the packaging looks.
What the MHRA advises
- Get prescription-only medicines only from a registered pharmacy, after a proper consultation.
- Avoid buying weight-loss injections from social media, marketplaces or unofficial websites.
- Report suspected side effects through the MHRA Yellow Card scheme.
- Use the MHRA #FakeMeds guidance on buying medicines online safely.
What is still unknown
The press release describes the seizure and the equipment, but it does not tell us how many of these pens had already reached customers, or what the seized pens actually contained once tested. Nothing in the release should be read as a statement that the contents were or were not the labelled drug. If you have used pens from an unregulated source and feel unwell, speak to a doctor and report it via Yellow Card.
For background on the drugs involved, see our pages on tirzepatide and retatrutide.
Common questions
Is retatrutide legal to buy in the UK?
According to the MHRA, retatrutide is not approved in the UK outside clinical trials, so products claiming to contain it are unlicensed and illegal to supply.
Where does the MHRA say to get weight-loss injections?
From a registered pharmacy with a valid prescription, not from social media, marketplaces or unofficial websites.